angiotensin ii has been researched along with Shock in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (48.06) | 18.7374 |
1990's | 5 (3.88) | 18.2507 |
2000's | 4 (3.10) | 29.6817 |
2010's | 30 (23.26) | 24.3611 |
2020's | 28 (21.71) | 2.80 |
Authors | Studies |
---|---|
Berry, TP; Haines, MM; Kozinn, J; Mohamed, A; Thomas, EL; Welge, JA; Zhurav, L | 1 |
Chen, A; Wong, A | 1 |
Ali, S; Awad, SS; Bird, S; Chand, M; Cornwell, LD; Jimenez, E; Schutz, A; Tran, TL | 1 |
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
Bansal, M; Belford, PM; Khanna, AK; Mehta, A; Vallabhajosyula, S; Wieruszewski, PM; Zhao, DX | 1 |
Bellomo, R; Boldt, DW; Busse, LW; Chow, JH; Deane, AM; Greenfeld, CR; Ham, KR; Hodges, T; Khanna, AK; Kroll, S; Ostermann, M; Wieruszewski, PM; Wunderink, RG; Zarbock, A | 1 |
Garcia, B; Legrand, M | 1 |
Engoren, MC; Mentz, GB; Smith, LM | 1 |
Alkazemi, A; Cocchi, MN; Eche, IM; Petri, CR; Sarge, T; Wong, A | 1 |
Russell, JA | 1 |
Allen, JM; Gilbert, BW | 1 |
Albertson, TE; Bellomo, R; Busse, LW; Chawla, LS; Deane, AM; English, SW; Handisides, DR; Khanna, AK; McCurdy, MT; Ostermann, M; Szerlip, H; Tidmarsh, GF; Wunderink, RG; Young, PJ | 1 |
Jansen, G; Morelli, A; Rehberg, S | 1 |
Chow, JH; McCurdy, MT; Wallis, MC; Winters, ME | 1 |
Albertson, TE; Busse, LW; Lee, CH; Nicholson, G; Nordyke, RJ; Zeng, F | 1 |
Chow, JH; Mazzeffi, MA; McCurdy, MT | 2 |
Bellomo, R; Beretta, L; Landoni, G; Morselli, F; Serpa Neto, A; Zangrillo, A | 1 |
Lumlertgul, N; Ostermann, M | 1 |
Casey, JD; Semler, MW | 1 |
Bobeck, KA; Brown, TE; Clark, PA; Holtzclaw, AW | 1 |
Boyd, JH; Gordon, AC; Kissoon, N; Russell, JA; Walley, KR; Williams, MD | 1 |
Bredeck, JF; Cutler, NS; Khanna, AK; Lata, AL; Rasmussen, BM | 1 |
Barreto, EF; Brown, DR; Butler, SO; Clark, AM; Cooper, CJ; Davison, DL; Gajic, O; Gunnerson, KJ; Kashani, KB; Mara, KC; Tendler, R; Wieruszewski, PM; Wittwer, ED | 1 |
Cutler, NS; Khanna, AK | 1 |
Al Husami, W; Alkhatib Tamimi, F; Ganatra, S; Liu, Y; Ofosu-Barko, K; Resnic, F; Shah, SP | 1 |
Chow, JH; Guo, Y; Hecht, J; Kethireddy, S; Mazzeffi, MA; McCurdy, MT; Newsome, AS; Smith, SE | 1 |
Patel, GP; Running, K; Sullivan, CL; Trudo, W; Weinberg, D | 1 |
Alam, A; Colbert, GB; Gill, J; Hughes, GJ; Mooney, JL; Ragula, N; Salem, M; Sovic, W | 1 |
Albertson, TE; Altaweel, L; Bellomo, R; Boldt, DW; Busse, LW; Chawla, LS; Chock, S; Deane, AM; English, SW; Favory, R; Gong, MN; Ham, K; Hästbacka, J; Jensen, J; Khanna, A; Krell, K; Kroll, S; Mackey, C; McCurdy, MT; Murugan, R; Ostermann, M; Panwar, R; Szerlip, H; Thompson, BT; Tidmarsh, GF; Tumlin, J; Venkatesh, B; Wang, XS; Wunderink, RG; Young, PJ | 1 |
Fernández-Ruiz, I | 1 |
Dellinger, RP; Trzeciak, S | 1 |
Agosta, S; Antonucci, E; Sakr, Y | 1 |
Bellomo, R; Khanna, A; Ostermann, M | 1 |
Antonucci, E; Gleeson, PJ | 1 |
Ali, O; Busse, LW; Chen, H; Hall, A; McCurdy, MT; Ostermann, M | 1 |
Ammar, H; Fouda, R | 1 |
Haeberle, HA; Rosenberger, P | 1 |
Dünser, MW; Meier, J | 1 |
Hertig, A; Jamme, M; Rafat, C | 1 |
Janssens, U | 1 |
Belletti, A; Landoni, G | 1 |
Bellomo, R; Bihorac, A; Busse, LW; Chawla, LS; Deane, AM; Finkel, KW; Forni, LG; Ham, KR; Jensen, J; Kashani, K; Kroll, S; Lynch, SJ; Murugan, R; Ostermann, M; Prowle, JR; Szerlip, HM; Tidmarsh, GF; Tumlin, JA; Zarbock, A | 1 |
Bissell, BD; Browder, K; Flannery, AH; McKenzie, M | 1 |
Buchtele, N; Jilma, B; Schwameis, M | 1 |
Bauer, SR; Lam, SW; Sacha, GL | 1 |
Boldt, DW; Gunnerson, K; Harper, MD; Lim, GW; Ostermann, M | 1 |
Abril, MK; Busse, LW; Handisides, D; Khanna, AK; Kroll, S; McNamara, C | 1 |
Benken, S; Cucci, M; Fernandez, E; Kane, S; Rodriguez, R | 1 |
Rascona, DA; Roy-Shapira, A | 1 |
Bellomo, R; Chawla, LS; Kroll, S; Tidmarsh, GF | 1 |
Busse, LW; Khanna, AK; Wakefield, BJ | 1 |
Khan, YA; McCredie, VA; Morales-Castro, D; Spring, J | 1 |
Antonucci, E; Taccone, FS | 1 |
Kleinsasser, A; Knotzer, H; Poidinger, B | 1 |
Johnson, PA; Thomovsky, E | 1 |
Alotaibi, Z; Brasha-Mitchell, E; Busse, LW; Chawla, LS | 1 |
Antunes-Rodrigues, J; Araujo, IG; Elias, LL; Mecawi, AS; Reis, LC; Vilhena-Franco, T | 1 |
DEL GRECO, F; JOHNSON, DC | 1 |
SPINK, WW; VICK, J | 1 |
FINSTAD, J; MELBY, JC; SPINK, WW; VICK, JA | 1 |
WEDEEN, R; ZUCKER, G | 1 |
BEANLANDS, DS; GUNTON, RW | 1 |
LARRAZASMITH, R; PORRASRAMIREZ, G; VAZQUEZNAVARRO, E | 1 |
BRUNNER, H; IMHOF, P; JACONO, A; QUITT, J; STEINMANN, B | 1 |
Arrigo, AP; Chen, Y; Currie, RW | 1 |
Dünser, MW; Friesenecker, BE; Hasibeder, WR; Knotzer, H; Mayr, AJ; Pajk, W; Schwarz, S; Ulmer, H; Wenzel, V | 1 |
Mouri, T; Murakami, O; Yoshinaga, K | 1 |
Altura, BM | 1 |
Börner, H; Klinkmann, H | 1 |
Miyazaki, M | 1 |
Bulkley, GB; Reilly, PM | 1 |
Renaud, LP | 1 |
Aneman, A; Eisenhofer, G; Fändriks, L; Friberg, P; Holm, M; Pettersson, A; von Bothmer, C | 1 |
Huang, WC; Tsai, LM | 1 |
Cassat, C; Desachy, A; François, B; Gastinne, H; Normand, S; Vignon, P | 1 |
Diaz, J; Mets, B; Pantuck, CB; Soo, E | 1 |
Ledingham, IM; Routh, GS | 1 |
Mitch, WE; Walker, WG | 1 |
Brown, CB | 1 |
Helmchen, U; Thurau, K | 1 |
Miyazaki, M; Yukioka, N | 1 |
Kovách, AG; Sándor, P | 1 |
Sander Jensen, K | 1 |
Szilagyi, JE | 1 |
Astrup, A; Bie, P; Christensen, NJ; Giese, J; Rørsgaard, S; Sander Jensen, K; Schwartz, TW; Secher, NH; Warberg, J | 1 |
Badder, EM; Duarte, B; Hamaji, M; Harrison, TS; Seaton, JF | 1 |
Cohn, JN; Luria, MH | 1 |
Magyar, S; Szabó, G | 1 |
Briguglio, FS; Perroni, G | 1 |
Botticelli, JT; Lange, RL; Tsagaris, TJ | 1 |
Faerchtein, I; Kastansky, I; Maciel, FS; Roque, AF | 1 |
Gemperle, M; Megevand, R; Moret, PR | 1 |
Bloch, JH; Dietzman, RH; Lillehei, RC; Lyons, GW | 1 |
Beck, R; Bucklitsch, W; Faulhaber, H; Gawellek, F; Grünewald, G | 1 |
Altura, BM; Hershey, SG | 2 |
Malhotra, RP; Singh, S | 2 |
Evreux, JC; Faucon, G; Frederich, A; Kofman, J; Lavarenne, J | 1 |
Adamska-Dyniewska, H | 1 |
Robb, HJ | 1 |
Brand, ED; Lefer, AM | 1 |
Enderlin, F; Gigon, JP; Wolff, G | 2 |
Collard, M; Evreux, JC; Faucon, G; Lavarenne, J; Perrot, E | 1 |
Kassel, H | 1 |
Markiewicz, M | 2 |
Litton, A | 1 |
Rex, H; Schulze, E | 1 |
Halmagyi, DF; Neering, IR; Pullin, J; Varga, D | 1 |
Chlup, J; Klener, P | 1 |
Lewis, CM; Weil, MH | 1 |
Schröder, R | 1 |
Chiri, A; Momo, D | 1 |
Samele Acquaviva, E | 1 |
Cohn, JN; Tristani, FE | 1 |
Bazaugour, R; Evreux, JC; Faucon, G; Perrot, E | 1 |
Wardle, EN | 1 |
Farrell, P; Fitzgerald, O; Fitzgerald, P; Geoghegan, C; Heffernan, A; McGeeney, K | 1 |
Habermann, E | 1 |
Hartel, W; Lenz, J; Linder, MM; Muschaweck, R | 1 |
Gross, F | 1 |
Ahlquist, RP | 1 |
Reubi, FC | 1 |
Reubi, F; Tuckman, J; Vorburger, C | 1 |
Reichmann, W | 1 |
Corbascio, AN; Smith, NT | 1 |
29 review(s) available for angiotensin ii and Shock
Article | Year |
---|---|
The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
Topics: Angiotensin II; Drug Overdose; Epinephrine; Humans; Norepinephrine; Shock; Vasoconstrictor Agents | 2022 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review.
Topics: Angiotensin II; Arterial Pressure; Humans; Norepinephrine; Peptide Hormones; Shock; Shock, Cardiogenic; Vasoconstrictor Agents | 2023 |
Vasopressor therapy in critically ill patients with shock.
Topics: Angiotensin II; Critical Illness; Dopamine; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2019 |
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
Topics: Angiotensin II; Critical Care; Humans; Shock; Vasoconstrictor Agents | 2019 |
Angiotensin II for the emergency physician.
Topics: Angiotensin II; Critical Care; Emergency Service, Hospital; Humans; Hypotension; Shock; Vasoconstrictor Agents | 2020 |
Roles of angiotensin II as vasopressor in vasodilatory shock.
Topics: Angiotensin II; Blood Pressure; Humans; Randomized Controlled Trials as Topic; Shock; Vasoconstrictor Agents; Vasodilation | 2020 |
Angiotensin II: A Review of Current Literature.
Topics: Angiotensin II; Humans; Shock; United States; Vasoplegia | 2022 |
Pharmacotherapy: Angiotensin II - a new tool in vasodilatory shock.
Topics: Angiotensin II; Blood Pressure; Humans; Shock; Vasoconstrictor Agents; Vasodilation | 2017 |
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
Topics: Angiotensin II; Blood Pressure; Humans; Monitoring, Physiologic; Shock | 2017 |
Angiotensin II increases blood pressure in patients with refractory vasodilatory shock.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Determination; Hemodynamics; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasodilation | 2018 |
A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
Topics: Angiotensin II; Animals; Humans; Shock; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock.
Topics: Angiotensin II; Drug-Related Side Effects and Adverse Reactions; Humans; Shock; Vasoconstrictor Agents; Vasopressins | 2018 |
Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
Topics: Adult; Angiotensin II; Arterial Pressure; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Shock; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2020 |
Angiotensin II in Vasodilatory Shock.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Female; Humans; Male; Middle Aged; Shock; Treatment Outcome; Vasoconstrictor Agents; Vasodilation | 2019 |
Pharmacologic Agents for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Catecholamines; Humans; Norepinephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2019 |
[Blood pressure regulation and shock].
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Endorphins; Hypertension; Nerve Tissue Proteins; Neurotensin; Rats; Rats, Inbred Strains; Shock; Substance P; Vasopressins | 1983 |
Microcirculatory and vascular smooth muscle behavior in the Brattleboro rat: relationship to reticuloendothelial system function and resistance to shock and trauma.
Topics: Angiotensin II; Animals; Aorta; Arterioles; Blood Pressure; Catecholamines; Diabetes Insipidus; Female; Homeostasis; Male; Microcirculation; Mononuclear Phagocyte System; Muscle Contraction; Muscle, Smooth, Vascular; Oxytocin; Phagocytosis; Rats; Rats, Brattleboro; Rats, Inbred Strains; Rats, Mutant Strains; Shock; Vasopressins; Wounds and Injuries | 1982 |
Pathogenesis of acute noninflammatory renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Humans; Kidney; Kidney Tubules; Nervous System Diseases; Prostaglandins; Regional Blood Flow; Renin; Shock | 1980 |
[Clinical indices for reversible and irreversible shock and their thresholds].
Topics: Angiotensin II; Animals; Cardiac Output; Humans; Lung; Mononuclear Phagocyte System; Pancreas; Renin; Shock; Shock, Cardiogenic | 1980 |
Vasoactive mediators and splanchnic perfusion.
Topics: Angiotensin II; Animals; Hemodynamics; Humans; Intestines; Ischemia; Shock; Splanchnic Circulation; Vasoconstriction | 1993 |
[Shock kidney (author's transl)].
Topics: Acute Kidney Injury; Angiotensin II; Animals; Chlorides; Glomerular Filtration Rate; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Tubules; Potassium; Rats; Regional Blood Flow; Renin; Shock; Sodium | 1978 |
Cerebral blood flow and brain function during hypotension and shock.
Topics: Acetylcholine; Angiotensin II; Animals; Brain; Brain Stem; Cardiac Output; Cerebellum; Cerebral Cortex; Cerebrovascular Circulation; Diencephalon; Electroencephalography; Epinephrine; Evoked Potentials; Humans; Hypotension; Hypothalamus; Hypoxia; Norepinephrine; Reflex; Regional Blood Flow; Serotonin; Shock; Shock, Hemorrhagic; Sympathetic Nervous System; Synapses; Vasomotor System | 1976 |
Heart and endocrine changes during central hypovolemia in man.
Topics: Aldosterone; Angiotensin II; Animals; Atropine; beta-Endorphin; Blood Pressure; Blood Volume; Endocrine Glands; Heart Rate; Humans; Myocardium; Pressoreceptors; Renin; Shock; Shock, Hemorrhagic; Vasopressins | 1991 |
Endogenous opiates and the pathogenesis of hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Endorphins; Hypertension; Hypertension, Renovascular; Models, Cardiovascular; Naloxone; Narcotics; Pain; Pressoreceptors; Shock | 1989 |
[Vasopressor drugs in shock due to myocardial infarction].
Topics: Angiotensin II; Epinephrine; Humans; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vasoconstrictor Agents | 1967 |
[Modern aspects of shock treatment].
Topics: Adrenal Cortex Hormones; Analgesics; Angiotensin II; Animals; Anti-Bacterial Agents; Buffers; Cardiac Glycosides; Catecholamines; Diuretics; Electrolytes; Fibrinolytic Agents; Humans; Plasma Substitutes; Rabbits; Rats; Shock; Sympatholytics; Transfusion Reaction; Vasopressins | 1968 |
[Mediators in shock processes: pathogenetic and therapeutic problems].
Topics: Acetylcholine; Adrenal Cortex Hormones; Anaphylaxis; Angiotensin II; Animals; Blood Vessels; Cell Membrane Permeability; Complement System Proteins; Dogs; Endotoxins; Haplorhini; Histamine; Humans; Kinins; Norepinephrine; Phospholipases; Rabbits; Serotonin; Shock; Shock, Hemorrhagic; Shock, Septic; Trypsin | 1971 |
The use and misuse of pressor agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthesia, Spinal; Angiotensin II; Blood Vessels; Dopamine; Ephedrine; Epinephrine; Felypressin; Glucagon; Heart; Humans; Isoproterenol; Mephentermine; Metaraminol; Methamphetamine; Methoxamine; Norepinephrine; Phenylephrine; Shock; Vasoconstrictor Agents | 1970 |
7 trial(s) available for angiotensin ii and Shock
Article | Year |
---|---|
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Topics: Angiotensin II; Humans; Hypotension; Norepinephrine; Prospective Studies; Shock; Vasoconstrictor Agents | 2023 |
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis.
Topics: Adult; Aged; Angiotensin II; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Life Expectancy; Male; Middle Aged; Models, Econometric; Organ Dysfunction Scores; Quality-Adjusted Life Years; Severity of Illness Index; Shock; United States; Vasoconstrictor Agents | 2020 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Aged; Angiotensin II; Blood Pressure; Catecholamines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension; Male; Middle Aged; Organ Dysfunction Scores; Shock; Vasoconstrictor Agents | 2017 |
Endocrinologic response to vasopressin infusion in advanced vasodilatory shock.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Endocrine Glands; Endothelin-1; Female; Hemodynamics; Humans; Hydrocortisone; Infusions, Intravenous; Male; Norepinephrine; Prolactin; Prospective Studies; Renin; Shock | 2004 |
[Use of hypertensin in the treatment of shock in myocardial infarct].
Topics: Adult; Aged; Angiotensin II; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Shock | 1965 |
Comparative study of angiotensin and nor-adrenaline in hypotensive states (shock).
Topics: Adolescent; Adult; Angiotensin II; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Norepinephrine; Shock | 1966 |
[Pathogenesis of acute kidney failure in shock and renal circulation in man].
Topics: Acute Kidney Injury; Angiotensin II; Catecholamines; Chromium Radioisotopes; Clinical Trials as Topic; Dye Dilution Technique; Edetic Acid; Hemodynamics; Humans; Indocyanine Green; Ischemia; Kidney; Kidney Glomerulus; Methods; Microscopy, Electron; Prostaglandins; Radioisotopes; Radionuclide Imaging; Regional Blood Flow; Renin; Shock; Sodium Isotopes; Xenon | 1973 |
93 other study(ies) available for angiotensin ii and Shock
Article | Year |
---|---|
Angiotensin II in Patients With Shock on Mechanical Circulatory Support: A Single-Center Retrospective Case Series.
Topics: Angiotensin II; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Shock; Shock, Cardiogenic | 2022 |
Evaluation of the Addition of Angiotensin II in Patients With Shock After Cardiac Surgery at a Veterans Affairs Medical Center.
Topics: Angiotensin II; Cardiac Surgical Procedures; Humans; Norepinephrine; Retrospective Studies; Shock; Vasoconstrictor Agents; Veterans | 2023 |
Adjunctive vasopressors in distributive shock: How soon is early?
Topics: Angiotensin II; Humans; Hypotension; Shock; Vasoconstrictor Agents | 2023 |
Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis.
Topics: Adult; Angiotensin II; Humans; Multiple Organ Failure; Retrospective Studies; Shock; Vasoconstrictor Agents | 2023 |
A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.
Topics: Adult; Angiotensin II; Catecholamines; Humans; Retrospective Studies; Shock; Vasoconstrictor Agents | 2020 |
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
Topics: Angiotensin I; Angiotensin II; Catecholamines; Female; Humans; Male; Shock | 2020 |
Selepressin for Patients With Septic Shock.
Topics: Angiotensin II; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2020 |
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.
Topics: Angiotensin II; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Shock; Vasoconstrictor Agents | 2020 |
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series.
Topics: Aged; Angiotensin II; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; Female; Humans; Infusions, Intravenous; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Shock; Vasoconstrictor Agents; Vasodilation | 2020 |
Renin, Angiotensin II, and the Journey to Evidence-based Individual Treatment Effects.
Topics: Angiotensin II; Catecholamines; Humans; Renin; Renin-Angiotensin System; Shock | 2020 |
Effective Use of Angiotensin II in Coronavirus Disease 19-Associated Mixed Shock State: A Case Report.
Topics: Aged, 80 and over; Angiotensin II; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Shock; Vasoconstrictor Agents | 2020 |
Vasopressor Therapy in the Intensive Care Unit.
Topics: Angiotensin II; Dopamine; Epinephrine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2021 |
Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
Topics: Angiotensin II; Critical Illness; Heart Transplantation; Humans; Prospective Studies; Shock; Vasoplegia | 2021 |
Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
Topics: Angiotensin II; Female; Hemodynamics; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Retrospective Studies; Shock; United States; Vasoconstrictor Agents | 2021 |
Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report.
Topics: Angiotensin II; Catecholamines; Humans; Hypotension; Shock; Vasoconstrictor Agents | 2020 |
Angiotensin II Administration in Patients With COVID-19 Shock.
Topics: Aged; Angiotensin II; Arterial Pressure; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock; Vasoconstrictor Agents | 2021 |
In Response.
Topics: Angiotensin II; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Shock | 2020 |
A Multicenter Observational Cohort Study of Angiotensin II in Shock.
Topics: Adult; Angiotensin II; Blood Pressure; Humans; Retrospective Studies; Shock; Vasoconstrictor Agents | 2022 |
Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report.
Topics: Angiotensin II; Humans; Hypotension; Liver Transplantation; Shock; Vasoconstrictor Agents | 2021 |
Angiotensin II for the Treatment of Vasodilatory Shock - Promise and Caution.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II in vasodilatory shock: lights and shadows.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Angiotensin II for the Treatment of Vasodilatory Shock.
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2017 |
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Topics: Acute Kidney Injury; Aged; Angiotensin II; Humans; Infusions, Intravenous; Middle Aged; Renal Replacement Therapy; Shock; Treatment Outcome | 2018 |
Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents | 2018 |
Angiotensin in ECMO patients with refractory shock.
Topics: Adult; Angiotensin II; Angiotensins; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Shock; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2018 |
Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiotensin II; Australia; Canada; Chi-Square Distribution; Europe; Female; Humans; Male; Middle Aged; Neurophysins; Norepinephrine; Prospective Studies; Protein Precursors; Retrospective Studies; Shock; Shock, Septic; United States; Vasoconstrictor Agents; Vasopressins; Young Adult | 2019 |
Blood Pressure Covariance Not Accounted for in Angiotensin II for the Treatment of High-Output Shock 3 Subgroup Analysis.
Topics: Angiotensin II; Blood Pressure; Humans; Patients; Renal Replacement Therapy; Shock | 2019 |
The authors reply.
Topics: Angiotensin II; Humans; Patients; Renal Replacement Therapy; Shock | 2019 |
Novel Considerations in the Management of Shock. Vasopressors, Fluid Responsiveness, and Blood Pressure Targets.
Topics: Angiotensin II; Blood Pressure; Humans; Shock; Vasoconstrictor Agents | 2019 |
Angiotensin II in ECMO patients: a word of caution.
Topics: Angiotensin II; Extracorporeal Membrane Oxygenation; Humans; Retrospective Studies; Shock | 2019 |
Shock pathophysiology.
Topics: Angiotensin II; Animals; Blood Circulation; Catecholamines; Hydrocortisone; Shock; Vasopressins | 2013 |
The use of angiotensin II in distributive shock.
Topics: Angiotensin II; Humans; Shock | 2016 |
Estradiol potentiates hypothalamic vasopressin and oxytocin neuron activation and hormonal secretion induced by hypovolemic shock.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular System; Estradiol; Female; Hypothalamus; Models, Animal; Neurons; Ovariectomy; Oxytocin; Paraventricular Hypothalamic Nucleus; Prolactin; Rats; Rats, Wistar; Shock; Supraoptic Nucleus; Vasopressins | 2011 |
Clinical experience with angiotensin II in the treatment of shock.
Topics: Angiotensin II; Convulsive Therapy; Shock | 1961 |
Canine endotoxin shock: reversal with aldosterone and angiotensin II (hypertensin).
Topics: Aldosterone; Angiotensin Amide; Angiotensin II; Animals; Antitoxins; Dogs; Endotoxins; Shock; Toxins, Biological | 1962 |
Influence of aldosterone and angiotensin II on endotoxin shock in the primate.
Topics: Aldosterone; Angiotensin II; Animals; Endotoxins; Humans; Hypertension; Primates; Shock; Shock, Septic | 1963 |
Angiotensin II in the treatment of shock.
Topics: Angiotensin II; Humans; Hypertension; Norepinephrine; Shock | 1963 |
ANGIOTENSIN II IN THE TREATMENT OF SHOCK FOLLOWING MYOCARDIAL INFARCTION.
Topics: Angiotensin II; Angiotensins; Blood Pressure; Drug Therapy; Epinephrine; Geriatrics; Humans; Infusions, Parenteral; Mortality; Myocardial Infarction; Shock | 1964 |
[CLINICAL EVALUATION OF ANGIOTENSIN II IN THE INITIAL PHASE OF SHOCK].
Topics: Angiotensin II; Angiotensins; Child; Drug Therapy; Geriatrics; Hypotension; Shock | 1964 |
[EXPERIMENTAL AND CLINICAL TESTS WITH BETA-ANGIOTENSIN II (PREPARATION CIBA 33 902-BA), A NEW ANGIOTENSIN II-ANALOGUE WITH INCREASED AND PROLONGED PRESSOR EFFECT].
Topics: Angiotensin II; Angiotensins; Drug Therapy; Humans; Hypotension; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasoconstrictor Agents | 1964 |
Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: a role for IKK depletion by heat shock?
Topics: Angiotensin II; Animals; Blood Pressure; Heat-Shock Proteins; Hot Temperature; HSP70 Heat-Shock Proteins; I-kappa B Kinase; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocarditis; Myocardium; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Shock | 2004 |
CNS pathways mediating cardiovascular regulation of vasopressin.
Topics: Angiotensin II; Blood Pressure; Cardiovascular Physiological Phenomena; Hypotension; Hypothalamus; Neurosecretory Systems; Pressoreceptors; Shock; Subfornical Organ; Vasopressins | 1996 |
Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function.
Topics: Angiotensin II; Animals; Bicarbonates; Duodenum; Enalaprilat; Guanethidine; Hemodynamics; Intestinal Mucosa; Membrane Potentials; Multiple Organ Failure; Norepinephrine; Renin-Angiotensin System; Shock; Splanchnic Circulation; Swine; Sympathetic Nervous System; Sympatholytics | 1997 |
Vascular expression of heat shock protein 72 in fructose-induced hypertensive rats.
Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; Fructose; Heat-Shock Proteins; Hot Temperature; HSP72 Heat-Shock Proteins; Hypertension; Male; Muscle, Smooth, Vascular; Norepinephrine; Rats; Rats, Sprague-Dawley; Shock | 1998 |
[Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Fluid Therapy; Humans; Lisinopril; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents | 2000 |
The effect of chronic cocaine administration on hemodynamic stability and neurohumoral mediators during isoflurane anesthesia and shock in rats.
Topics: Anesthesia; Anesthetics, Inhalation; Angiotensin II; Animals; Arginine Vasopressin; Cocaine; Epinephrine; Hemodynamics; Isoflurane; Male; Norepinephrine; Rats; Shock; Vasoconstrictor Agents | 2001 |
The pathophysiology of shock.
Topics: Angiotensin II; Blood Circulation; Blood Viscosity; Body Fluids; Catecholamines; Heart; Hematocrit; Histamine; Humans; Hydrogen-Ion Concentration; Kidney; Kinins; Liver; Lung; Oxygen Consumption; Oxyhemoglobins; Prostaglandins; Respiration; Shock; Shock, Cardiogenic; Vasoconstriction; Vasodilation | 1979 |
Plasma renin and angiotensin II in acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Blood Pressure; Creatinine; Humans; Hypotension, Controlled; Kidney; Kidney Function Tests; Oliguria; Osmolar Concentration; Renin; Shock; Surgical Procedures, Operative | 1977 |
Shock and the kidney: pathophysiology and pharmacological support.
Topics: Acute Kidney Injury; Adrenocorticotropic Hormone; Angiotensin II; Catecholamines; Diuretics; Glomerular Filtration Rate; Hemodynamics; Humans; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Renal Dialysis; Shock; Vasodilator Agents | 1977 |
Renal blood flow in various types of hypotension and shock in dogs and men (preliminary report).
Topics: Angiotensin II; Animals; Catecholamines; Dogs; Hemodynamics; Humans; Hypotension, Controlled; Kidney; Regional Blood Flow; Renin; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic | 1978 |
[Circulatory regulation during hypovolemic shock].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pancreatic Polypeptide; Posture; Shock; Vasopressins | 1986 |
Angiotensin II restoration of reflex adrenal medullary secretion to anephric dogs is physiologically dose dependent.
Topics: Adrenal Glands; Adrenal Medulla; Angiotensin II; Animals; Catecholamines; Dogs; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Kidney; Nephrectomy; Norepinephrine; Reflex; Secretory Rate; Shock | 1985 |
Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran.
Topics: Adult; Aged; Angiotensin II; Cardiac Output; Dextrans; Hemodynamics; Humans; Hypotension; Metaraminol; Middle Aged; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents | 1965 |
The role of angiotensinase activity in the diminished pressor response to angiotensin.
Topics: Angiotensin II; Animals; Blood; Blood Pressure; Dogs; Endopeptidases; In Vitro Techniques; Peptide Hydrolases; Shock; Tachyphylaxis | 1965 |
[First clinical experiences on the use of beta-angiotensin II. Treatment of a grave case of shock].
Topics: Adult; Anaphylaxis; Angiotensin II; Female; Humans; Obstetric Labor Complications; Pregnancy; Shock | 1965 |
Mechanisms of pressor amine dependence.
Topics: Adult; Aged; Angiotensin II; Blood Circulation; Blood Volume; Cardiac Output; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Kidney Function Tests; Male; Metaraminol; Middle Aged; Norepinephrine; Shock; Water-Electrolyte Balance | 1965 |
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate; Humans; Isoproterenol; Mephentermine; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance | 1966 |
Relation of cardiac work to survival in cardiogenic shock in dogs.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Dextrans; Dogs; Electricity; Hemodynamics; Isoproterenol; Norepinephrine; Phenoxybenzamine; Shock; Transducers; Vascular Resistance | 1967 |
[Clinical studies of the effectiveness of hypertensin under conditions of anesthesia and shock].
Topics: Adult; Aged; Anesthesia; Angiotensin II; Female; Humans; Male; Middle Aged; Shock | 1966 |
Influence of vasoexcitor-pressor drugs on microvascular injury in shock.
Topics: Angiotensin II; Animals; Appendix; Blood Vessels; Mesentery; Norepinephrine; Rats; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasoconstrictor Agents; Vasomotor System | 1967 |
[Influence of angiotensin on cardiac output in shock].
Topics: Angiotensin II; Animals; Cardiac Output; Dogs; Shock | 1966 |
Electrocardiographic moniteering of patients of shock on angiotensin and noradrenaline therapy.
Topics: Adolescent; Adult; Angiotensin II; Electrocardiography; Female; Humans; Male; Middle Aged; Norepinephrine; Shock | 1967 |
Microphysiology of vasopressors in shock.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Metaraminol; Methoxamine; Motion Pictures; Norepinephrine; Photomicrography; Rabbits; Regional Blood Flow; Shock; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 1967 |
Influence of positive inotropic agents on the action of a myocardial depressant factor in the plasma of cats in postoligemic shock.
Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Volume; Cardiac Glycosides; Cats; Female; Male; Muscle Contraction; Norepinephrine; Ouabain; Shock; Sympathomimetics | 1967 |
[Shock therapy with vasodilator and-or vasoconstrictor agents].
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diuresis; Female; Humans; Isoproterenol; Norepinephrine; Sepsis; Shock; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents | 1967 |
[The treatment of shock with isoproterenol].
Topics: Adult; Aged; Angiotensin II; Blood Circulation; Female; Humans; Isoproterenol; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Pulmonary Embolism; Shock; Shock, Hemorrhagic; Shock, Septic | 1966 |
[Absence of favorable effects of pressor agents on cardiac output and peripheral circulatory flow in advanced shock].
Topics: Angiotensin II; Animals; Cardiac Output; Dogs; Epinephrine; Female; Male; Norepinephrine; Shock | 1968 |
[Inzellen--hypertensin in the treatment of severe shock].
Topics: Adult; Angiotensin II; Asparagine; Female; Humans; Infusions, Parenteral; Magnesium; Potassium; Shock | 1968 |
[Results of treatment of myocardial infarction associated with shock in relation to the kind of administered drugs].
Topics: Adult; Aged; Angiotensin II; Epinephrine; Female; Humans; Hydrocortisone; Male; Middle Aged; Morphine; Myocardial Infarction; Shock; Strophanthins | 1968 |
Microvascular effects of vasoactive agents in shock.
Topics: Aged; Angiotensin II; Animals; Arteries; Blood; Blood Vessels; Cheek; Cricetinae; Epinephrine; Female; Humans; Norepinephrine; Phenoxybenzamine; Phentolamine; Plasma; Shock; Vasoconstrictor Agents; Veins | 1968 |
Sustained complete autonomic blockade.
Topics: Angiotensin II; Animals; Atropine; Autonomic Nerve Block; Blood Pressure; Cardiac Output; Dogs; Dopamine; Epinephrine; Ganglia, Autonomic; Sheep; Shock; Time Factors; Trimethaphan | 1969 |
Results of treatment of myocardial infarction accompanied by shock in relation to drugs applied.
Topics: Adult; Aged; Angiotensin II; Female; Humans; Hydrocortisone; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Shock | 1969 |
[Incidence of cardiogenic shock in patients with acute myocardial infarct. A few remarks on mortality and therapeutic possibilities].
Topics: Angiotensin II; Cardiac Output; Female; Humans; Injections, Intravenous; Male; Myocardial Infarction; Norepinephrine; Shock | 1969 |
Hemodynamic spectrum of vasopressor and vasodilator drugs.
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Epinephrine; Heart Rate; Hemodynamics; Isoproterenol; Metaraminol; Methoxamine; Norepinephrine; Phenoxybenzamine; Phentolamine; Phenylephrine; Shock; Sympatholytics; Vasoconstrictor Agents; Vasodilator Agents | 1969 |
[Importance of regional circulation for treatment of cardiogenic shock].
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Cardiac Output; Dogs; Epinephrine; Heart Rate; Hemodynamics; Humans; Lactates; Metaproterenol; Myocardial Infarction; Oxygen Consumption; Pyruvates; Regional Blood Flow; Shock; Vascular Resistance; Veins | 1969 |
[Our clinical experience with a new hypertensive drug: beta-L-angiotensin II (Ciba 33'902 BA)].
Topics: Adolescent; Adult; Angiotensin II; Burns; Female; Humans; Intestinal Obstruction; Male; Middle Aged; Shock; Shock, Traumatic; Wounds and Injuries | 1968 |
[Treatment of hypotension in anesthesiological practice. Indications and limitations of modern hypotensive drugs].
Topics: Anesthesia; Angiotensin II; Epinephrine; Humans; Hypotension; Norepinephrine; Octopamine; Shock; Synephrine | 1969 |
Studies in clinical shock and hypotension. VII. Renal hemodynamics before and during treatment.
Topics: Acetylcholine; Adult; Aged; Angiotensin II; Blood Flow Velocity; Blood Urea Nitrogen; Cardiac Output; Dextrans; Dopamine; Dye Dilution Technique; Humans; Hydralazine; Hypotension; Isoproterenol; Kidney; Male; Metaraminol; Middle Aged; Norepinephrine; Plasma Substitutes; Regional Blood Flow; Shock; Vascular Resistance; Vasoconstrictor Agents | 1970 |
[Risks of secondary circulatory failure at the time of excessive perfusion with vasoconstrictor agents].
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Carbon Dioxide; Dogs; Epinephrine; Female; Hydrocortisone; Hypotension; Infusions, Parenteral; Lactates; Male; Oxygen Consumption; Phentolamine; Shock; Vasoconstrictor Agents | 1970 |
Radio-fibrinogen studies in renal hypertension.
Topics: Acidosis; Anemia, Hemolytic; Angiotensin II; Animals; Aorta; Desoxycorticosterone; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemolysis; Hypertension; Hypertension, Renal; Hypoxia; Ligation; Methoxamine; Nephrectomy; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Rabbits; Rats; Renal Artery; Serum Albumin, Radio-Iodinated; Shock; Uremia | 1971 |
Shock in acute pancreatitis and hypovolaemia.
Topics: Acute Disease; Angiotensin II; Animals; Blood Volume; Dogs; Hypotension; Macroglobulins; Pancreatitis; Shock; Trypsin | 1972 |
[Therapy of shock using vaso- and coagulation-active substances. Behavior of tissue oxygen in the dog kidney under the influence of vaso- and coagulation-active substances].
Topics: Angiotensin II; Animals; Dogs; Kidney; Norepinephrine; Oxygen Consumption; Shock; Streptokinase; Thrombin; Vasoconstrictor Agents | 1972 |
[Letter: Hypertensin].
Topics: Angiotensin II; Blood Pressure; Coronary Vessels; Heart; Kidney; Norepinephrine; Oxygen Consumption; Shock | 1973 |
Pharmacology of pressor agents on the systemic circulation.
Topics: Action Potentials; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Epinephrine; Humans; Isoproterenol; Mephentermine; Metaraminol; Methoxamine; Norepinephrine; Phenylephrine; Pituitary Hormones, Posterior; Receptors, Adrenergic; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Vasoconstrictor Agents | 1973 |
The pathogenesis of anuria following shock.
Topics: Acute Kidney Injury; Aminohippuric Acids; Angiotensin II; Animals; Anuria; Blood Pressure; Chromium Radioisotopes; Edetic Acid; Glomerular Filtration Rate; Humans; Indicator Dilution Techniques; Indocyanine Green; Inulin; Kidney; Kidney Function Tests; Norepinephrine; Prostaglandins; Radioisotopes; Regional Blood Flow; Renin; Shock; Sodium Isotopes | 1974 |
Reticuloendothelial function in experimental injury and tolerance to shock.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Catheterization; Female; Intestine, Large; Ischemia; Mononuclear Phagocyte System; Norepinephrine; Phagocytes; Phagocytosis; Rats; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasopressins | 1972 |
[On the regulation of kidney blood circulation. Animal experiment studies by means of renal vein catheterization].
Topics: Acetylcholine; Angiotensin II; Animals; Atropine; Blood Circulation; Blood Pressure; Carbon Dioxide; Cardiac Catheterization; Catheterization; Chloralose; Dogs; Electrocardiography; Ergotamine; Ethanolamines; Ethyl Ethers; Femoral Artery; Femoral Vein; Halothane; Isoproterenol; Kidney; Nitroglycerin; Norepinephrine; Nucleosides; Shock; Urethane; Vasoconstrictor Agents; Vasodilator Agents | 1966 |